PSC Partners Canada Annual Research Grant Awards
The 2023 research grant cycle has not yet opened. Schedule to be released by August 1, 2023. Please check back.
The Grant Process will be revised for 2023.
2022 Grant Application Process
Application Deadlines for 2022 Proposal Submissions
- Letter of Intent submission deadline: 05/16/2022
- Proposal submission deadline: 07/18/2022
- Scientific/Medical Advisory Committee (SMAC) meeting: TBD-Sept. 2022
Letter of Intent
Prospective applicants are requested to submit a letter of intent (LOI) which should include the following:
- Describe title of proposed research
- Name, address, and email address of the Principal Investigator(s)
- Names of other key personnel
- Participating institutions
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains assists the Scientific/Medical Advisory Committee to estimate the potential review workload and plan the review.
Please submit your LOI to contactus@pscpartners.org by 05/16/2022
We make grants to fund research that addresses an important and novel, basic or clinical question related to PSC, based upon a competitive research proposal review process. PSC Partners Canada participates in the review process administered by US-based PSC Partners Seeking a Cure.
Please note that applications are to be submitted to PSC Partners Seeking a Cure in the US by email to contactus@pscpartners.org and will be considered for funding by both the US and Canadian organizations. Please submit only one application.
The Scientific/Medical Advisory Committee reviews all proposals and makes recommendations. The Canada Board of Directors determines if research grant(s) will be made by PSC Partners Canada.
Eligibility for Canadian Funding
Eligibility is based upon Canadian charity law.
- Researchers at Canadian hospitals and universities are eligible.
- For researchers at institutions outside of Canada to be eligible, the institution must be on this list of prescribed universities outside Canada maintained by the Canada Revenue Agency.
Please note that eligibility for funding from the US-based PSC Partners Seeking a Cure organization is not governed by these constraints; this applies to Canada funding only.
History of Grants Program
In 2009, US-based PSC Partners Seeking a Cure awarded its first set of research grants. For PSC Partners, this was a milestone, an important step towards taking us closer to new treatments and an eventual cure. PSC Partners Canada joined the grants program in 2016. Since the inception of the program, together, over US$4,000,000 has been allocated to promising PSC research projects (as of Feb 2020). The Canadian PSC Partners affiliate has directly funded over CAD $650,000 in research grants. Details can be found here.
We thank our Canadian donors who have supported our mission of raising funds to research causes, treatments and cures for primary sclerosing cholangitis. Your contributions have made these awards possible.
All research proposals are reviewed annually by the PSC Partners’ Scientific/Medical Advisory (SMAC) Committee. Details of Canadian-funded grants can be found here.
